Rinvoq ER 15 MG tablet UU 30S

Ended Awarded

Contract number
SPE2DR26FC1EM
Awardee
Awarding agency
Obligated
$25,396

Award facts

Contract value 100% obligated
$25,396.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $25,396.12 delivery order to Amerisourcebergen Drug Corp on July 16, 2026, for RINVOQ ER 15 mg tablets (30-count unit of use packaging).

The order is firm fixed price with an ultimate completion date of July 17, 2026, and performance in Conshohocken, PA. The order carries no set-aside designation. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution under the Defense Logistics Agency's standing indefinite delivery contract structure for medical supply chain procurement.

Quick answers

Who was awarded contract SPE2DR26FC1EM?

SPE2DR26FC1EM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 16, 2026.

How much is contract SPE2DR26FC1EM worth?

The government has obligated $25,396 on SPE2DR26FC1EM.

Is contract SPE2DR26FC1EM an order under another contract?

Yes. SPE2DR26FC1EM is a delivery order under SPE2DR25D2212, an indefinite delivery contract.

Was contract SPE2DR26FC1EM competed?

The extent of competition for SPE2DR26FC1EM was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award